CryoPort (NASDAQ:CYRX) Shares Down 7.8%

Share on StockTwits

CryoPort Inc (NASDAQ:CYRX)’s stock price was down 7.8% on Friday . The stock traded as low as $21.42 and last traded at $21.89, approximately 1,126,144 shares traded hands during trading. An increase of 301% from the average daily volume of 280,686 shares. The stock had previously closed at $23.73.

Several research analysts recently weighed in on CYRX shares. B. Riley set a $26.00 price target on CryoPort and gave the company a “buy” rating in a research report on Friday, July 19th. Svb Leerink reissued an “outperform” rating on shares of CryoPort in a research report on Monday, July 15th. BidaskClub raised CryoPort from a “hold” rating to a “buy” rating in a research report on Thursday, August 15th. Needham & Company LLC started coverage on CryoPort in a research report on Monday, July 1st. They set a “buy” rating and a $22.00 price target on the stock. Finally, Leerink Swann assumed coverage on CryoPort in a research report on Monday, July 15th. They set a “buy” rating and a $24.00 price target on the stock. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. CryoPort presently has a consensus rating of “Buy” and an average target price of $24.00.

The company has a current ratio of 17.73, a quick ratio of 17.68 and a debt-to-equity ratio of 0.17. The firm has a 50-day simple moving average of $20.95 and a two-hundred day simple moving average of $16.09. The company has a market capitalization of $844.62 million, a price-to-earnings ratio of -70.61 and a beta of 0.82.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Thursday, August 8th. The consumer goods maker reported ($0.08) earnings per share for the quarter, hitting the consensus estimate of ($0.08). CryoPort had a negative return on equity of 17.32% and a negative net margin of 35.71%. The company had revenue of $8.46 million for the quarter, compared to analyst estimates of $7.94 million. During the same period in the prior year, the firm posted ($0.09) EPS. The business’s revenue was up 82.7% compared to the same quarter last year. On average, sell-side analysts forecast that CryoPort Inc will post -0.3 earnings per share for the current year.

A number of hedge funds have recently modified their holdings of the business. D. E. Shaw & Co. Inc. increased its position in CryoPort by 1.6% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 48,429 shares of the consumer goods maker’s stock worth $887,000 after purchasing an additional 783 shares during the last quarter. Rhumbline Advisers increased its position in CryoPort by 3.1% in the 1st quarter. Rhumbline Advisers now owns 34,962 shares of the consumer goods maker’s stock worth $452,000 after purchasing an additional 1,043 shares during the last quarter. Greenwood Capital Associates LLC increased its position in CryoPort by 5.8% in the 2nd quarter. Greenwood Capital Associates LLC now owns 20,014 shares of the consumer goods maker’s stock worth $367,000 after purchasing an additional 1,100 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in CryoPort by 2.2% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 64,566 shares of the consumer goods maker’s stock worth $1,183,000 after purchasing an additional 1,402 shares during the last quarter. Finally, Taylor Wealth Management Partners increased its position in CryoPort by 0.7% in the 2nd quarter. Taylor Wealth Management Partners now owns 299,830 shares of the consumer goods maker’s stock worth $5,493,000 after purchasing an additional 2,050 shares during the last quarter. 47.41% of the stock is currently owned by institutional investors.

CryoPort Company Profile (NASDAQ:CYRX)

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Further Reading: What Are Cryptocurrencies?

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Gateley Holdings PLC  to Distribute Dividend of GBX 5.40 on  October 16th
Gateley Holdings PLC to Distribute Dividend of GBX 5.40 on October 16th
Equiniti Group PLC Plans Dividend of GBX 1.95
Equiniti Group PLC Plans Dividend of GBX 1.95
Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies


 
© 2006-2019 Zolmax.